Financial insights of ARWR

MyFinsight

For the year ending 2025-09-30, ARWR made $829,448K in revenue. -$1,631K in net income. Net profit margin of -0.20%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30
Revenue	829,448
Research and development	607,159
General and administrative	123,943
Total operating expenses	731,102
Operating income (loss)	98,346
Interest income	37,289
Interest expense	89,361
Other, net	5,259
Total other expense	-46,813
Income (loss) before income tax expense and noncontrolling interest	51,533
Income tax expense (benefit)	21,419
Net income (loss) including noncontrolling interest	30,114
Net income (loss) attributable to noncontrolling interest, net of tax	31,745
Net loss attributable to arrowhead pharmaceuticals, inc	-1,631

Basic (in dollars per share)	-0.01
Basic (in shares)	133,758,000
Diluted (in dollars per share)	-0.01
Diluted (in shares)	133,758,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30
Revenue	829,448
Research and development	607,159
General and administrative	123,943
Total operating expenses	731,102
Operating income (loss)	98,346
Interest income	37,289
Interest expense	89,361
Other, net	5,259
Total other expense	-46,813
Income (loss) before income tax expense and noncontrolling interest	51,533
Income tax expense (benefit)	21,419
Net income (loss) including noncontrolling interest	30,114
Net income (loss) attributable to noncontrolling interest, net of tax	31,745
Net loss attributable to arrowhead pharmaceuticals, inc	-1,631

Basic (in dollars per share)	-0.01
Basic (in shares)	133,758,000
Diluted (in dollars per share)	-0.01
Diluted (in shares)	133,758,000

Financial insights of ARWR